Beroe LiVE.Ai™

AI-powered self-service platform for all your sourcing decision needs across 1,200+ categories like Injectors .

Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.

Schedule a Demo

Injectors Market Monitoring Dashboard

Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™

Schedule a Demo

Injectors Industry Benchmarks

Savings Achieved

(in %)

The average annual savings achieved in Injectors category is 5.15%

Payment Terms

(in days)

The industry average payment terms in Injectors category for the current quarter is 54.3 days

Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™

Category Strategy and Flexibility

Engagement Model

Supply Assurance

Sourcing Process

Supplier Type

Pricing Model

Contract Length


Lead Time

Supplier Diversity

Targeted Savings

Risk Mitigation

Financial Risk



Geopolitical Risk

Cost Optimization

Price per Unit Competitiveness

Specification Leanness

Minimum Order Quality

Payment Terms

Inventory Control

Schedule a Demo
Meet Abi

The World’s first Digital Market Analyst

    Meet Abi

    The World’s first Digital Market Analyst

    Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions

    Abi is now supercharged with GPT4 AI engine. Enjoy the ease of ChatGPT, now on Abi

    Injectors Market Intelligence

    global market outlook

      • The global self-injecting device market was valued at ~$43.1 billion in 2020 and is expected to reach $152.63 billion by 2026 at a CAGR of ~23.4 percent..
      • Growth is being driven by new drugs introduced in the market requiring delivery by injection (~40 percent of drugs under development are expected to be delivered parenterally requiring some form of injector), increase in incidence of chronic diseases like diabetes, new product development, among others.
      • There is a growing need for injection devices especially for home use which can increase the quality of life for patients.
      • In the US, due to increase in diabetes population, there is a huge demand for autoinjectors. Additionally, rising awareness for home healthcare settings boosts the demand for technologically advanced autoinjectors, which drives the price of the product.
      • The global injectors market is fragmented, and the key players are Flex, Jabil, Elcam Medical, Cambridge Consultants Inc and Oval Medical Technologies.

    Injectors market report transcript

    Injectors Global Market Outlook:


    Global market size: $6.7 Billion (2021)

    Expected to grow at a CAGR of 5-7 percent to $16.2 billion by 2026

    • With reference to article by Ji Lin et al. published in Population Health Metrics Journal 2018, the anticipated number and percent of adults diagnosed with diabetes would increase from 22.3 million (9.1 percent) in 2014 to 39.7 million (13.9 percent) in 2030 and to 60.6 million (17.9 percent) in 2060

    • The number of people with diabetes aged ≥65 years are expected to increase from 9.2 million in 2014 to 21.0 million in 2030 and to 35.2 million in 2060

    • With increasing prevalence of chronic diseases, the demand for self-injection device, which is used for treatment or recovery from such diseases, is expected to increase

    Porter's Analysis on Injectors

    Supplier Power

    • The supplier market for injectors has established players with global presence. The market is value based, as the devices are expensive

    • Moreover, generic players are entering the market to reduce the monopoly

    • Hence, the supplier power varies from medium to high

    Barriers to New Entrants

    • Huge medical, R&D expertise, capital requirements make it difficult for new entrants

    • Huge competition and majority of the companies profits depend on volume of sales

    • Meeting global regulatory requirements, a key challenge for medium to complex medical

    • Need to have a good distribution network to offer better products and after-sales services

    • Presence of established players in the market

    Intensity of Rivalry

    • Existing competition is strong among the top players viz., Ypsomed, BD, etc.

    • Continuous innovation in the market, coupled with a huge demand for injectors, leaves the intensity of the rivalry as high among suppliers

    Threat of Substitutes

    • Traditional injections, prefilled syringes, another type of injectors, are economical alternatives to self-injecting devices

    • However, increase in inclination toward homecare self-injecting devices for chronic patients and increasing advances to increase patient compliance threat of substitute remain low to medium

    Buyer Power

    • Bargaining power for medical device clients is medium to low, as suppliers are constantly innovating to provide better patient compliance features

    Injectors Cost Structure Analysis

    • Technological advancements for the administration of large volume and high-viscosity drugs drive the demand for autoinjectors in the market, hence raw materials and components contribute to the major portion of manufacturing, since the critical components are important, which needs to work each time of usage without fail

    • Raw Materials & Components Cost: 1.8 mg of sodium chloride costs ~28 percent; 0.5 mg of sodium metabisulfites costs ~1 percent, and 0.3 mg epinephrine costs ~72 percent to manufacture per pack of lifesaving Epipen. Critical components, such as outer sleeve, syringe casing, contribute to higher price in manufacturing per pack Epipen

    • Labor and Technology Cost: Adoption of the latest technology drives the spend on R&D to develop new products will also lead to an increase in the cost of the products. Assembling an Epipen requires well-trained labor with technical knowledge

    • Packaging & Labeling: One box of secondary package with label costs approximately 20 percent and the instruction manual costs ~4 percent

    Interesting Reads:

    Discover the world of market intelligence and how it can elevate your business strategies.

    Learn more about how market intelligence can enable informed decision-making, help identify growth opportunities, manage risks, and shape your business's strategic direction.

    Get Ahead with AI-Enabled Market Insights Schedule a Demo Now

    Schedule a Demo Now